Lcepda Trademark Details

This mark is alive with a status of Second Extension - Granted. The last case file activity for this mark occured 7 years ago on Tuesday, July 12, 2016, according to the United State Patent & Trademark Office
Word Mark Lcepda
Status Alive 731 — Second Extension - Granted

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 86304149
Status Date Tuesday, July 12, 2016
Filing Date Tuesday, July 12, 2016
Attorney Xiomara Triana

Correspondent

XIOMARA TRIANA
BRISTOL-MYERS SQUIBB COMPANY
TRADEMARKS DEPT MS D33-05
PO BOX 4000
PRINCETON, NJ 08543-4000

Case File Statements

Goods & Services Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Friday, June 20, 2014
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.